Dr. Bellingan will present the data from the Athersys ARDS trial. His presentation is titled “Primary Analysis of a Phase 1/2 Study to Assess MultiStem® Cell Therapy, a Regenerative Advanced Therapy Medicinal Product (ATMP), in Acute Respiratory Distress Syndrome (MUST-ARDS)”
Monday May 20, 2019 9:15 AM - 11:15 AM